Manal Amoury

Leptin Receptor Signaling in T Cells Is Required for Th17 Differentiation

Bernardo Sgarbi Reis, Kihyun Lee, Melania H. Fanok et al. · The Journal of Immunology · 2015 · 160 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model

Manal Amoury, Katharina Kolberg, Anh‐Tuan Pham et al. · Cancer Letters · 2016 · 43 citations

Medicine, Oncology, Pharmacology +13

A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein

Manal Amoury, Radoslav Mladenov, Thomas Nachreiner et al. · International Journal of Cancer · 2016 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +14

Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand

Manal Amoury, Dirk Bauerschlag, Felix Zeppernick et al. · Oncotarget · 2016 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

One Year Follow-up on the First Patient Treated with Nula-Cel: An Autologous CRISPR/Cas9 Gene Corrected CD34+ Cell Product to Treat Sickle Cell Disease

David C. Shyr, Robert Lowsky, Weston P. Miller et al. · Blood · 2023 · 24 citations

Life Sciences, Biotechnology, Genetics +15